Advancing Healthcare Through Cutting-Edge Innovation
Brinter AM Technologies is thrilled to announce our participation in the Additive Manufacturing for the Life Sciences (AM4Life) consortium, a visionary initiative funded by VINNOVA. By joining forces with over 35 leading partners from academia, industry, and healthcare, we are set to accelerate breakthroughs in 3D printing for medical applications. This strategic alliance represents a significant step forward in transforming how regenerative medicine, implant technology, and tissue engineering are developed and deployed.
Driving Innovation in Life Sciences with Additive Manufacturing
AM4Life is dedicated to advancing the field of Additive Manufacturing (AM) for life sciences by creating robust synergies among diverse experts. The consortium focuses on resolving key challenges, including:
- Biodegradable, Patient-Specific Implants: Developing 3D-printed implants that gradually degrade as new tissue grows, minimizing complications and enhancing patient outcomes.
- Advanced Tissue and Organ Printing: Leveraging bioprinting techniques to create complex tissue structures, moving us closer to the goal of printing functional organs for transplantation.
- Smart 3D-Printed Devices: Integrating sensors and advanced materials into printed devices, enabling real-time monitoring and improved therapeutic functionalities.
- High-Resolution Printing Technologies: Pushing the limits of current 3D printing capabilities to fabricate intricate micro-architectures that replicate natural biological systems.
AM4Life brings together academic researchers, industrial experts, and healthcare professionals to foster an environment where innovative ideas are rapidly transformed into practical, life-saving solutions.
The Brinter AM Technologies Commitment
At Brinter AM Technologies, our passion for advanced manufacturing and biomedical innovation drives us to constantly push the boundaries of what is possible. Our role in AM4Life is defined by our commitment to:
- Leveraging Advanced 3D Printing Solutions: Utilizing our state-of-the-art printing platforms and expertise to contribute to the development of next-generation bioactive materials and devices.
- Innovative Research and Development: Pioneering efforts in the field of high-resolution and multi-material printing, we are focused on overcoming the technical challenges that impede the creation of reliable, scalable healthcare solutions.
- Collaboration and Knowledge Sharing: Working closely with academic and healthcare partners, we aim to ensure that innovations are seamlessly translated from the lab to clinical practice. This collaboration is at the heart of accelerating research breakthroughs and enhancing patient care.
Our active participation in AM4Life allows us to apply our unique capabilities in additive manufacturing to create tangible impacts in regenerative medicine and personalized healthcare.
A Collaborative Platform Backed by VINNOVA
The AM4Life consortium is powered by VINNOVA, Sweden’s Innovation Agency, and represents a forward-thinking approach to healthcare innovation. With a funding model that equally supports academia, industry, and public sector initiatives, the consortium is uniquely positioned to deliver groundbreaking results over its 10-year timeline (2020–2029). As AM4Life enters its second phase (2025–2029), it brings together an even broader network of partners—23 industrial, 9 academic, and 3 public organisations—ensuring a diverse and dynamic approach to tackling today’s healthcare challenges.
Looking Ahead: Phase 2 Ambitions
In the upcoming phase of AM4Life, the focus will be on scaling up innovations and deepening collaborative efforts. The goals are ambitious: from significantly increasing the number of scientific publications and patent applications to developing a range of new products and processes that enhance patient care. We at Brinter AM Technologies are excited to be at the forefront of this evolution, driving forward research that brings us closer to making personalized, 3D-printed medical solutions a clinical reality.
Join Us on the Journey
We invite you to follow Brinter AM Technologies and the AM4Life consortium as we work together to revolutionize healthcare through additive manufacturing. Stay connected for updates on our progress, breakthrough research, and opportunities to collaborate in transforming life sciences.
Together, let’s build the future of healthcare—one innovative layer at a time!
For further updates, follow our page on LinkedIn
Funded by the European Union. Views and opinions expressed are however those of the author(s) only and do not necessarily reflect those of the European Union or HaDEA. Neither the European Union nor the granting authority can be held responsible for them.
